187 related articles for article (PubMed ID: 37293201)
1. Mechanistic inhibition of Monkeypox and Marburg virus infection by O-rhamnosides and Kaempferol-o-rhamnosides derivatives: a new-fangled computational approach.
Al Mashud MA; Kumer A; Mukerjee N; Chandro A; Maitra S; Chakma U; Dey A; Akash S; Alexiou A; Khan AA; Alanazi AM; Ghosh A; Chen KT; Sharma R
Front Cell Infect Microbiol; 2023; 13():1188763. PubMed ID: 37293201
[TBL] [Abstract][Full Text] [Related]
2. Investigation of the New Inhibitors by Sulfadiazine and Modified Derivatives of α-D-glucopyranoside for White Spot Syndrome Virus Disease of Shrimp by In Silico: Quantum Calculations, Molecular Docking, ADMET and Molecular Dynamics Study.
Kumer A; Chakma U; Rana MM; Chandro A; Akash S; Elseehy MM; Albogami S; El-Shehawi AM
Molecules; 2022 Jun; 27(12):. PubMed ID: 35744817
[TBL] [Abstract][Full Text] [Related]
3. Modified coptisine derivatives as an inhibitor against pathogenic
Akash S; Hossain A; Mukerjee N; Sarker MMR; Khan MF; Hossain MJ; Rashid MA; Kumer A; Ghosh A; León-Figueroa DA; Barboza JJ; Padhi BK; Sah R
Front Pharmacol; 2023; 14():1140494. PubMed ID: 37153804
[TBL] [Abstract][Full Text] [Related]
4. Anti-viral drug discovery against monkeypox and smallpox infection by natural curcumin derivatives: A Computational drug design approach.
Akash S; Hossain A; Hossain MS; Rahman MM; Ahmed MZ; Ali N; Valis M; Kuca K; Sharma R
Front Cell Infect Microbiol; 2023; 13():1157627. PubMed ID: 37033493
[TBL] [Abstract][Full Text] [Related]
5. Identifying potential monkeypox virus inhibitors: an
Ashley CN; Broni E; Wood CM; Okuneye T; Ojukwu MT; Dong Q; Gallagher C; Miller WA
Front Cell Infect Microbiol; 2024; 14():1351737. PubMed ID: 38500508
[TBL] [Abstract][Full Text] [Related]
6. Design and development of new inhibitors against breast cancer, Monkeypox and Marburg virus by modification of natural Fisetin via in silico and SAR studies.
Akash S; Rahman MM; Gonçalves Lima CM; Emran TB; Sultana S; Naz S; Aziz T; Alharbi M; Alshammari A; Alasmari AF
Acta Biochim Pol; 2023 Sep; 70(3):599-600. PubMed ID: 37677069
[TBL] [Abstract][Full Text] [Related]
7. Drug repurposing for Mpox: Discovery of small molecules as potential inhibitors against DNA-dependent RNA polymerase using molecular modeling approach.
Dutt M; Kumar A; Rout M; Dehury B; Martinez G; Ndishimye P; Kelvin AA; Kelvin DJ
J Cell Biochem; 2023 May; 124(5):701-715. PubMed ID: 36946432
[TBL] [Abstract][Full Text] [Related]
8. Screening of potential inhibitors against structural proteins from Monkeypox and related viruses of
Kaur M; Sharma A; Kaur H; Singh M; Devi B; Naresh Raj AR; Sood V; Pandey A; Gartia J; Kumar R; Suresh Babu AR; Singh G; Barnwal RP
J Biomol Struct Dyn; 2023 Sep; ():1-16. PubMed ID: 37776002
[TBL] [Abstract][Full Text] [Related]
9. Natural photosensitizers potentiate the targeted antimicrobial photodynamic therapy as the Monkeypox virus entry inhibitors: An in silico approach.
Pourhajibagher M; Bahador A
Photodiagnosis Photodyn Ther; 2023 Sep; 43():103656. PubMed ID: 37336465
[TBL] [Abstract][Full Text] [Related]
10. Computer-assisted drug repurposing for thymidylate kinase drug target in monkeypox virus.
Ajmal A; Mahmood A; Hayat C; Hakami MA; Alotaibi BS; Umair M; Abdalla AN; Li P; He P; Wadood A; Hu J
Front Cell Infect Microbiol; 2023; 13():1159389. PubMed ID: 37313340
[TBL] [Abstract][Full Text] [Related]
11. A drug design strategy based on molecular docking and molecular dynamics simulations applied to development of inhibitor against triple-negative breast cancer by Scutellarein derivatives.
Akash S; Aovi FI; Azad MAK; Kumer A; Chakma U; Islam MR; Mukerjee N; Rahman MM; Bayıl I; Rashid S; Sharma R
PLoS One; 2023; 18(10):e0283271. PubMed ID: 37824496
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive Virtual Screening of the Antiviral Potentialities of Marine Polycyclic Guanidine Alkaloids against SARS-CoV-2 (COVID-19).
El-Demerdash A; Metwaly AM; Hassan A; Abd El-Aziz TM; Elkaeed EB; Eissa IH; Arafa RK; Stockand JD
Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33808721
[TBL] [Abstract][Full Text] [Related]
13. Identification of Kaempferol as Viral Entry Inhibitor and DL-Arginine as Viral Replication Inhibitor from Selected Plants of Indian Traditional Medicine against COVID-19: An
Jayaprakashkamath A; Murali M; Nair B; Benny F; Mani RP; Suresh D; Presanna AT; Areekkara AN; Nath LR
Curr Comput Aided Drug Des; 2023; 19(4):313-323. PubMed ID: 36635906
[TBL] [Abstract][Full Text] [Related]
14. Exploring the effectiveness of flavone derivatives for treating liver diseases: Utilizing DFT, molecular docking, and molecular dynamics techniques.
Quayum ST; Esha NJI; Siraji S; Abbad SSA; Alsunaidi ZHA; Almatarneh MH; Rahman S; Alodhayb AN; Alibrahim KA; Kawsar SMA; Uddin KM
MethodsX; 2024 Jun; 12():102537. PubMed ID: 38299040
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, antimicrobial, SAR, PASS, molecular docking, molecular dynamics and pharmacokinetics studies of 5'-
Munia NS; Hosen MA; Azzam KMA; Al-Ghorbani M; Baashen M; Hossain MK; Ali F; Mahmud S; Shimu MSS; Almalki FA; Hadda TB; Laaroussi H; Naimi S; Kawsar SMA
Nucleosides Nucleotides Nucleic Acids; 2022; 41(10):1036-1083. PubMed ID: 35797068
[TBL] [Abstract][Full Text] [Related]
16. In-silico targeting TMPK from monkey pox virus: Molecular docking analysis, density functional theory studies and molecular dynamic simulation analysis.
Sib Tul Hassan Shah S; Naeem I
J Biomol Struct Dyn; 2023; 41(24):14689-14701. PubMed ID: 36970852
[TBL] [Abstract][Full Text] [Related]
17. Pharmacophore modelling-based drug repurposing approaches for monkeypox therapeutics.
Alagarsamy V; Shyam Sundar P; Raja Solomon V; Narendhar B; Sulthana MT; Rohitha K; Dhanwar S; Dharshini Aishwarya A; Murugesan S
J Biomol Struct Dyn; 2023 Dec; 41(20):10678-10689. PubMed ID: 36905675
[TBL] [Abstract][Full Text] [Related]
18. Identification of a novel farnesoid X receptor agonist, kaempferol-7-O-rhamnoside, a compound ameliorating drug-induced liver injury based on virtual screening and in vitro validation.
Liu K; Chen X; Ren Y; Liu C; Yuan A; Zheng L; Li B; Zhang Y
Toxicol Appl Pharmacol; 2022 Nov; 454():116251. PubMed ID: 36150480
[TBL] [Abstract][Full Text] [Related]
19. Probing intermolecular interactions and binding stability of kaempferol, quercetin and resveratrol derivatives with PPAR-γ: docking, molecular dynamics and MM/GBSA approach to reveal potent PPAR- γ agonist against cancer.
Lokhande KB; Ballav S; Yadav RS; Swamy KV; Basu S
J Biomol Struct Dyn; 2022 Feb; 40(3):971-981. PubMed ID: 32954977
[TBL] [Abstract][Full Text] [Related]
20. An In silico Investigation to Identify Promising Inhibitors for SARS-CoV-2 M
Alagarsamy V; Sundar PS; Narendhar B; Sulthana MT; Kulkarni VS; Aishwarya AD; Solomon VR; Murugesan S; Jubie S; Rohitha K; Dhanwar S
Med Chem; 2023; 19(9):925-938. PubMed ID: 37069723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
